Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» AstraZeneca auctions off troubled psoriasis drug to Valeant in $445M deal
AstraZeneca auctions off troubled psoriasis drug to Valeant in $445M deal
AstraZeneca auctions off troubled psoriasis drug to Valeant in $445M deal
Submitted by
admin
on September 1, 2015 - 9:55am
Source:
Fierce Biotech
News Tags:
AstraZeneca
Valeant Pharmaceuticals
psoriasis
brodalumab
Headline:
AstraZeneca auctions off troubled psoriasis drug to Valeant in $445M deal
Do Not Allow Advertisers to Use My Personal information
